Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 93,352 | 83,803 | 112,248 | 110,432 | -25,795 | -- |
| General And Administrative Expense | 107,147 | 82,303 | 106,494 | 103,891 | 112,992 | -- |
| Other Operating Expenses | 2,288 | 25,569 | 15,058 | 10,701 | 292,221 | -- |
| Operating Expense | 95,640 | 109,372 | 127,306 | 121,133 | 266,426 | -- |
| Operating Income | -95,640 | -109,372 | -127,306 | -121,133 | -266,426 | -- |
| EBIT | -95,640 | -109,372 | -127,306 | -121,133 | -266,426 | -- |
| Interest Income | -3,324 | 7,611 | 3,932 | 19,252 | 7,223 | -- |
| Interest Income Non Operating | -3,324 | 7,611 | 3,932 | 19,252 | 7,223 | -- |
| Net Interest Income | -3,324 | 7,611 | 3,932 | 19,252 | 7,223 | -- |
| Other Income Expense | 6,957 | -- | 83,418 | 48,954 | 774,227 | -60,221 |
| Special Income Charges | -- | -- | -- | -- | -- | -400,084 |
| Gain On Sale Of Security | 6,957 | -- | 83,418 | 48,954 | 374,143 | -60,221 |
| Pretax Income | -92,007 | -101,761 | -39,956 | -52,927 | 515,024 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 116,134 | -- |
| Net Income From Continuing And Discontinued Operation | -92,007 | -101,761 | -39,956 | -52,927 | 515,024 | -- |
| Net Income From Continuing Operation Net Minority Interest | -92,007 | -101,761 | -39,956 | -52,927 | 515,024 | -- |
| Net Income Including Noncontrolling Interests | -92,007 | -101,761 | -39,956 | -52,927 | 515,024 | -- |
| Net Income Common Stockholders | -92,007 | -101,761 | -39,956 | -52,927 | 515,024 | -- |
| Net Income | -92,007 | -101,761 | -39,956 | -52,927 | 515,024 | -- |
| EBITDA | -95,640 | -109,372 | -127,306 | -121,133 | -266,426 | -- |
| Normalized EBITDA | -102,597 | -109,372 | -210,724 | -170,087 | -1.0M | -- |
| Basic EPS | -- | -0.00 | 0.00 | -0.00 | -- | -0.01 |
| Diluted EPS | -- | -0.00 | 0.00 | -0.00 | -- | -0.01 |
| Basic Average Shares | -- | 39.4M | 30.1M | 25.9M | -- | 25.9M |
| Diluted Average Shares | -- | 39.4M | 30.1M | 25.9M | -- | 25.9M |
| Total Unusual Items | 6,957 | -- | 83,418 | 48,954 | 774,227 | -60,221 |
| Total Unusual Items Excluding Goodwill | 6,957 | -- | 83,418 | 48,954 | 774,227 | -60,221 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | -- |
| Normalized Income | -98,964 | -101,761 | -123,374 | -101,881 | -143,069 | -- |
| Diluted NI Availto Com Stockholders | -92,007 | -101,761 | -39,956 | -52,927 | 515,024 | -- |
| Impairment Of Capital Assets | -- | -- | -- | -- | -- | 400,084 |
| Insurance And Claims | 6,465 | 6,471 | 9,068 | 9,073 | 9,116 | -- |
| Net Income Continuous Operations | -92,007 | -101,761 | -39,956 | -52,927 | 515,024 | -- |
| Net Non Operating Interest Income Expense | -3,324 | 7,611 | 3,932 | 19,252 | 7,223 | -- |
| Other Gand A | 100,682 | 75,832 | 97,426 | 71,418 | 103,876 | -- |
| Salaries And Wages | 0.00 | 0.00 | 0.00 | 23,400 | 0.00 | -- |
| Selling And Marketing Expense | -- | 1,500 | 5,754 | 6,541 | -- | 15,546 |
| Total Expenses | 95,640 | 109,372 | 127,306 | 121,133 | 266,426 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 1.9M | 2.0M | 2.1M | 690,122 | 719,205 | -- |
| Cash Cash Equivalents And Short Term Investments | 1.9M | 2.0M | 2.1M | 1.5M | 1.4M | -- |
| Cash Financial | 1.9M | 2.0M | 2.1M | 690,122 | 719,205 | -- |
| Other Short Term Investments | 28,826 | 0.00 | 0.00 | 773,228 | 724,274 | -- |
| Receivables | 13,880 | 13,956 | 80,879 | 64,457 | 155,304 | -- |
| Prepaid Assets | 36,918 | 62,328 | 18,259 | 25,811 | 41,734 | -- |
| Current Assets | 2.0M | 2.0M | 2.2M | 1.6M | 1.6M | -- |
| Net PPE | -- | -- | -- | -- | -- | 423,026 |
| Total Non Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Assets | 2.0M | 2.0M | 2.2M | 1.6M | 1.6M | -- |
| Payables And Accrued Expenses | 49,407 | 16,464 | 48,993 | 23,492 | 80,864 | -- |
| Current Deferred Revenue | -- | -- | -- | -- | 0.00 | 0.00 |
| Current Liabilities | 49,407 | 16,464 | 48,993 | 23,492 | 80,864 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 49,407 | 16,464 | 48,993 | 23,492 | 80,864 | -- |
| Common Stock | 8.4M | 8.4M | 8.4M | 7.8M | 7.8M | -- |
| Capital Stock | 8.4M | 8.4M | 8.4M | 7.8M | 7.8M | -- |
| Additional Paid In Capital | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | -- |
| Retained Earnings | -8.6M | -8.5M | -8.4M | -8.4M | -8.4M | -- |
| Common Stock Equity | 1.9M | 2.0M | 2.1M | 1.5M | 1.6M | -- |
| Stockholders Equity | 1.9M | 2.0M | 2.1M | 1.5M | 1.6M | -- |
| Total Equity Gross Minority Interest | 1.9M | 2.0M | 2.1M | 1.5M | 1.6M | -- |
| Total Capitalization | 1.9M | 2.0M | 2.1M | 1.5M | 1.6M | -- |
| Net Tangible Assets | 1.9M | 2.0M | 2.1M | 1.5M | 1.6M | -- |
| Tangible Book Value | 1.9M | 2.0M | 2.1M | 1.5M | 1.6M | -- |
| Working Capital | 1.9M | 2.0M | 2.1M | 1.5M | 1.6M | -- |
| Invested Capital | 1.9M | 2.0M | 2.1M | 1.5M | 1.6M | -- |
| Share Issued | 39.4M | 39.4M | 39.4M | 25.9M | 25.9M | -- |
| Ordinary Shares Number | 39.4M | 39.4M | 39.4M | 25.9M | 25.9M | -- |
| Current Deferred Liabilities | -- | -- | -- | -- | 0.00 | 0.00 |
| Other Equity Interest | -- | -- | -- | -- | -- | 2,064 |
| Other Receivables | 2,080 | 2,080 | -- | -- | -- | -- |
| Taxes Receivable | 11,800 | 11,876 | 80,879 | 64,457 | 155,304 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -62,404 | -111,436 | -106,743 | -29,083 | -258,903 | -- |
| Cash Flow From Continuing Operating Activities | -62,404 | -111,436 | -106,743 | -29,083 | -258,903 | -- |
| Stock Based Compensation | 0.00 | 0.00 | 0.00 | 23,400 | 0.00 | -- |
| Change In Working Capital | 58,429 | -9,675 | 16,631 | 49,398 | 300.00 | -- |
| Change In Receivables | 76.00 | 66,923 | -16,422 | 90,847 | -38,524 | -- |
| Change In Payables And Accrued Expense | 32,943 | -32,529 | 25,501 | -57,372 | 16,486 | -- |
| Purchase Of PPE | -- | -- | -- | -- | -- | 0.00 |
| Net PPE Purchase And Sale | -- | -- | -- | -- | -- | 0.00 |
| Sale Of Investment | -- | 0.00 | -- | -- | -- | 0.00 |
| Net Investment Purchase And Sale | -- | 0.00 | -- | -- | -- | 0.00 |
| Investing Cash Flow | 0.00 | 0.00 | -- | -- | -- | 0.00 |
| Cash Flow From Continuing Investing Activities | -- | 0.00 | -- | -- | -- | 0.00 |
| Issuance Of Capital Stock | 0.00 | 0.00 | -- | -- | 0.00 | 0.00 |
| Net Common Stock Issuance | 0.00 | 0.00 | -- | -- | 0.00 | 0.00 |
| Financing Cash Flow | 0.00 | 0.00 | -- | -- | 0.00 | -41,250 |
| Cash Flow From Continuing Financing Activities | 0.00 | 0.00 | -- | -- | 0.00 | -41,250 |
| Changes In Cash | -62,404 | -111,436 | 1.4M | -29,083 | -107,763 | -- |
| Beginning Cash Position | 2.0M | 2.1M | 690,122 | 719,205 | 826,968 | -- |
| End Cash Position | 1.9M | 2.0M | 2.1M | 690,122 | 719,205 | -- |
| Free Cash Flow | -62,404 | -111,436 | -106,743 | -29,083 | -223,903 | -- |
| Change In Prepaid Assets | 25,410 | -44,069 | 7,552 | 15,923 | 22,338 | -- |
| Common Stock Issuance | 0.00 | 0.00 | -- | -- | 0.00 | 0.00 |
| Net Income From Continuing Operations | -92,007 | -101,761 | -39,956 | -52,927 | 515,024 | -- |
| Net Other Financing Charges | 0.00 | 0.00 | -- | -- | -- | -- |
| Net Other Investing Changes | -- | -- | -- | -- | -- | -114,323 |
| Unrealized Gain Loss On Investment Securities | -6,957 | 0.00 | -83,418 | -48,954 | -374,143 | -- |